ArticleBMC cancer2015

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

S Rahal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.